Finance

Beta
Lists
APLIF:OTCMKTS
Appili Therapeutics Inc
$0.012
0.00%
(0.00) 1D
May 29, 1:01:23 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for APLIF...
Mkt. cap
1.49M
Avg. vol.
25.01K
Volume
0.00
52-wk high
$0.03
52-wk low
$0.01
Beta
-0.13
Shares outstanding
128.37M
No. of employees
7
Mkt. cap
1.49M
Avg. vol.
25.01K
Volume
0.00
52-wk high
$0.03
52-wk low
$0.01
Beta
-0.13
Shares outstanding
128.37M
No. of employees
7
News stories
From sources across the web
About Appili Therapeutics Inc
CEO-
Employees7
Founded2015
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CAD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-12.61K
-
103.94K
114.98K
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1.53M
960.97K
832.83K
575.34K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
993.15K
642.47K
569.75K
256.96K
Operating expense
2.52M
1.60M
1.40M
832.29K
Total operating expenses
2.52M
1.60M
1.40M
832.29K
Operating income
-2.53M
-1.60M
-1.30M
-717.31K
Other non operating income
3.34M
550.89K
223.07K
-9.61K
EBT including unusual items
255.68K
-1.22M
-954.10K
-939.68K
EBT excluding unusual items
255.68K
-1.22M
-954.10K
-939.68K
Income tax expense
27.64K
30.86K
34.97K
9.82K
Effective tax rate
10.81%
-2.53%
-3.66%
-1.04%
Other operating expenses
-
-
-
-
Net income
228.05K
-1.25M
-989.06K
-949.50K
Net profit margin
-1,809.06%
-
-951.62%
-825.79%
Earnings per share
-
-
-
-
Interest and investment income
-
-
218.44K
-
Interest expense
-669.55K
-486.07K
-
-378.19K
Net interest expenses
-669.55K
-486.07K
218.44K
-378.19K
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.53M
-1.60M
-1.30M
-715.02K
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more